Home › Compare › SIOX vs VICI

SIOX vs VICI: Dividend Comparison 2026

SIOX yields 91.00% · VICI yields 6.57%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SIOX wins by $1.69M in total portfolio value
10 years
SIOX
SIOX
● Live price
91.00%
Share price
$0.48
Annual div
$0.44
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.68M
Annual income
$847,016.42
Full SIOX calculator →
VICI
VICI Properties Inc.
● Live price
6.57%
Share price
$27.12
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$988.8K
Annual income
$623,261.32
Full VICI calculator →

Portfolio growth — SIOX vs VICI

📍 SIOX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSIOXVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SIOX + VICI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SIOX pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SIOX
Annual income on $10K today (after 15% tax)
$7,735.36/yr
After 10yr DRIP, annual income (after tax)
$719,963.96/yr
VICI
Annual income on $10K today (after 15% tax)
$558.67/yr
After 10yr DRIP, annual income (after tax)
$529,772.12/yr
At 15% tax rate, SIOX beats the other by $190,191.84/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SIOX + VICI for your $10,000?

SIOX: 50%VICI: 50%
100% VICI50/50100% SIOX
Portfolio after 10yr
$1.83M
Annual income
$735,138.87/yr
Blended yield
40.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

SIOX
Analyst Ratings
1
Buy
2
Hold
1
Sell
Consensus: Hold
Altman Z
-17.3
Piotroski
2/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+16.5% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SIOX buys
0
VICI buys
0
No recent congressional trades found for SIOX or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSIOXVICI
Forward yield91.00% ✓6.57%
Annual dividend / share$0.44$1.78 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3% ✓
Portfolio after 10y$2.68M$988.8K ✓
Annual income after 10y$847,016.42 ✓$623,261.32
Total dividends collected$2.37M$948.4K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy

Year-by-year: SIOX vs VICI ($10,000, DRIP)

YearSIOX PortfolioSIOX Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$19,800$9,100.42$11,368$948.43+$8.4K → SIOX
2$38,027$16,840.38$13,339$1,493.16+$24.7K → SIOX
3$70,915$30,226.23$16,326$2,426.21+$54.6K → SIOX
4$128,559$52,680.24$21,123$4,112.15+$107.4K → SIOX
5$226,813$89,254.37$29,379$7,368.23+$197.4K → SIOX
6$389,856$147,166.82$44,804$14,191.64+$345.1K → SIOX
7$653,555$236,408.67$76,658$29,972.12+$576.9K → SIOX
8$1,069,692$370,388.16$150,894$71,015.81+$918.8K → SIOX
9$1,711,136$566,565.23$350,814$193,582.47+$1.36M → SIOX
10$2,677,932$847,016.42$988,809$623,261.32+$1.69M → SIOX

SIOX vs VICI: Complete Analysis 2026

SIOX — Stock

Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.

Full SIOX Calculator →

VICI — REIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this SIOX vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SIOX vs SCHDSIOX vs JEPISIOX vs OSIOX vs KOSIOX vs MAINSIOX vs NNNSIOX vs EPRTSIOX vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.